Alnylam Pharmaceuticals, Inc. (ALNY)

320.13 -13.26 (-3.98%) USD  |  NASDAQ  |  Apr 16, 16:00
321.13 +1.00 (+0.31%) After-Hours: 20:00
More

Alnylam Pharmaceuticals Revenue Per Employee (Annual)

Revenue Per Employee (Annual) Chart

View Revenue Per Employee (Annual) for ALNY.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Revenue Per Employee (Annual) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Revenue Per Employee (Annual) Range, Past 5 Years

View Revenue Per Employee (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Revenue Per Employee (Annual) Benchmarks

View Revenue Per Employee (Annual) Benchmarks
Start Trial
Pfizer Inc. Upgrade
Eli Lilly & Co. Upgrade
Ionis Pharmaceuticals, Inc. Upgrade
Regeneron Pharmaceuticals, Inc. Upgrade
Sarepta Therapeutics, Inc. Upgrade